Parallax Volatility Advisers, L.P. Guardant Health, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $1,607 - $3,184	100 Added 1.69%	6,000 $173,000
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $126,761 - $199,134	-7,400 Reduced 55.64%	5,900 $121,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $287,014 - $392,350	13,300 New	13,300 $359,000
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $2.95 Million - $4.12 Million	67,600 New	67,600 $3.64 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $2.74 Million - $4.14 Million	25,000 New	25,000 $3.11 Million
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $1.14 Million - $1.55 Million	-11,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $915,647 - $1.27 Million	11,400 New	11,400 $1.27 Million
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $6.96 Million - $11.2 Million	-115,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $1.92 Million - $2.89 Million	32,500 Added 39.39%	115,000 $8 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $4.91 Million - $6.83 Million	82,500 New	82,500 $6.45 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.